Award-winning University of Strathclye spinout company, Microplate Dx Limited has recently secured significant seed funding to scale-up development of its game-changing diagnostic test.
Liverpool ChiroChem Ltd. (LCC), an investee company within Deepbridge Capital's Life Science EIS fund, has recently raised £2.2 million of investment from a panel of regional investors to expand its team and continue its global operation from within the United Kingdom. Deepbridge Capital contributed £1.2m to this round.
"As we approach the new year, many will be starting to think about the coming year and what challenges and opportunities may avail themselves. Here are my thoughts on what advisers might be expecting to consider in 2023."